Gelonghui, November 6 | According to the Southwest Securities Research Report, international medicine (000516.SZ) focuses on core hospitals to create a highland of medical services in the northwest. The Xi'an High-tech Hospital under the company is the first top three social medical hospital in China, with 1,500 open beds; Xi'an International Medical Center Hospital is a tertiary general hospital built according to the top three standards, with a planned capacity of 5037 beds. The two major core hospitals can reduce the current shortage of high-quality medical resources in the central and western regions. On the other hand, the company actively lays out fields such as medical aesthetics, rehabilitation medicine, and assisted reproduction. The business structure will continue to be optimized, and the company is working hard to set sail. The bank expects the company to have a market value of 30.05 billion yuan in 2024, corresponding to a stock price of 13.29 yuan, maintaining a “buy” rating.